![Hiroko Ogihara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hiroko Ogihara
No open positions remaining
Net worth: 6 M $ as of 2026-06-29
Health Technology
Profile
Hiroko Ogihara was the Chairman of KYORIN Pharmaceutical Co., Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Noile-Immune Biotech, Inc.
 Noile-Immune Biotech, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of CAR-T cell therapy based therapeutic cancer drugs 18.85% | 2025-12-30 | 8,159,550 ( 18.85% ) | 6 M $ | 2026-06-29 |
Former positions of Hiroko Ogihara
| Companies | Position | End |
|---|---|---|
| KYORIN PHARMACEUTICAL CO., LTD. | Chairman | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
KYORIN Pharmaceutical Co., Ltd.
 KYORIN Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals through its subsidiaries | Health Technology |
- Stock Market
- Insiders
- Hiroko Ogihara
